ããã« ã¿ã©ãœ ã«ã³ã¿ããªãŒã³ ã©ã¹ ã·ã¬ãã¹ 4 ã¹ãŒããªã¢ã®ã¹ãã¯ã宿æ³å®¢ããè³åŠäž¡è«ã®è©äŸ¡ãåããŠããŸããçŽ æŽããããæé«ãå¿«é©ã§éåžžã«æ¥œãããåè¶ãããµãŒãã¹ãšããªãŒãã¡ã³ããæäŸããŠãããšããè¯å®çãªæèŠãããäžæ¹ã§ãå€ãã®å®¿æ³å®¢ãããã€ãã®æ¬ ç¹ãææããŠããŸãã
äž»ãªæžå¿µäºé
ãšããŠãã¹ãã®èŠæš¡ãéåžžã«å°ãããšããç¹ãæããããå€ãã®å Žåãæ··éããŠãããšãããŠããŸãããã®éãããã¹ããŒã¹ã¯ãCOVID-19ã®åœ±é¿ã§å容人æ°ãå¶éãããŠããã«ãããããããããŒã¯æã«ã¯ç¹ã«åé¡ãšãªã£ãŠããŸããããã«ãã¹ãæœèšã¯ããã«ãšã¯å¥ã®å»ºç©ã«äœçœ®ããŠãããå€ãæ©ãå¿
èŠããããããç¹ã«å¯ãææã«ã¯äžäŸ¿ã§ãã
ã¹ãã®å©çšæéãè°è«ã®çãšãªã£ãŠããŸããå®¿æ³æéã«å«ãŸããŠããããä»ã®ããã«ãšæ¯èŒããŠããªãé«é¡ã§ãããšèãã人ãããŸããã¹ãã®å©çšã«ã¯å¥éäºçŽãå¿
èŠã§ããããšã«äžæºãæããè¿œå æéãé«ããšæããŠãã人ãããŸããã¹ãã®å¶æ¥æéãå®¶æåãã®ã¹ã±ãžã¥ãŒã«ããäžäŸ¿ã§ãããšææãããŠããŸãã
ãããã®åé¡ã«ãããããããã¹ãã®ããªãŒãã¡ã³ãã¯å¥œè©ã§ãå©çšå¯èœãªæ§ã
ãªãããµãŒãžãçŸå®¹ãµãŒãã¹ãæšå¥šãã人ãå€ãããŸãããªã©ãã¯ã¹ããã°ã©ã ããµãŒãã«ãµãŒãããã¯ãçãã¹ããŒã¹ã®å¶çŽã®äžã§ããå¿å°ããéé¿ãæäŸããŠããããšé«ãè©äŸ¡ãããŠããŸãã
çµè«ãšããŠãããã« ã¿ã©ãœ ã«ã³ã¿ããªãŒã³ ã©ã¹ ã·ã¬ãã¹ 4 ã¹ãŒããªã¢ã®ã¹ãã¯ãç¹ã«ããªãŒãã¡ã³ãã®è³ªãšãµãŒãã¹ã«ãããŠåŒ·ã¿ãããäžæ¹ã§ããã®å°ããªèŠæš¡ã远å è²»çšãäžäŸ¿ãªå Žæããå®å
šã«å¥œæçãªäœéšãæãªã£ãŠããŸãã